DRGEM Corporation (KOSDAQ:263690)
South Korea · Delayed Price · Currency is KRW 5,340.00
+10.00 (0.19%)
At close: Mar 27, 2026
DRGEM Revenue
In the year 2025, DRGEM had annual revenue of 102.75B KRW, down -1.21%. DRGEM had revenue of 27.88B in the quarter ending December 31, 2025, with 18.77% growth.
Revenue
102.75B
Revenue Growth
-1.21%
P/S Ratio
0.57
Revenue / Employee
383.38M
Employees
268
Market Cap
58.18B
Revenue Chart
Revenue History
| Fiscal Year End | Revenue | Change | Growth |
|---|---|---|---|
| Dec 31, 2025 | 102.75B | -1.26B | -1.21% |
| Dec 31, 2024 | 104.01B | -8.91B | -7.89% |
| Dec 31, 2023 | 112.92B | 2.75B | 2.50% |
| Dec 31, 2022 | 110.17B | 24.41B | 28.47% |
| Dec 31, 2021 | 85.75B | -20.85B | -19.56% |
| Dec 31, 2020 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
| Dec 31, 2019 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
| Dec 31, 2018 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
| Dec 31, 2017 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
| Dec 31, 2016 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
Revenue Definition
Revenue, also called sales, is the amount of money a company receives from its business activities, such as sales of products or services. Revenue does not take any expenses into account and is therefore different from profits.
Full DefinitionRelated Stocks
| Company Name | Revenue |
|---|---|
| Genoray | 102.75B |
| JPI Healthcare | 52.79B |
| CU Medical Systems | 44.79B |
| Hironic | 33.18B |
| Remed | 24.50B |
| Neofect | 16.05B |
| MEKICS CO., | 11.29B |
| Noul Co.,Ltd. | 3.91B |